Literature DB >> 36193230

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature.

Jillian L Peters1, Amary Fall2, Steven D Langerman1, Margueritta El Asmar1, Mari Nakazawa1, Aishat Mustapha1, Aaron A R Tobian2, Heba H Mostafa2, Joel N Blankson1.   

Abstract

We describe the case of a patient with AIDS who had persistent infection with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant for >80 days. The variant contained mutations that were not present in other Delta viruses in our hospital. Prolonged infection in immunosuppressed individuals may lead to evolution of SARS-CoV-2 lineages.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  COVID-19; SARS-CoV2; HIV; PLWH

Year:  2022        PMID： 36193230      PMCID： PMC9494428          DOI： 10.1093/ofid/ofac479

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   4.423


  31 in total

1.  Prolonged SARS-CoV-2 shedding in a person living with advanced HIV and diffuse large B-cell lymphoma: a case report.

Authors:  Irfaan Maan; Stavroula Maria Paraskevopoulou; Kate Cwynarski; Meena Shrestha; Laura Waters; Robert Miller; Nadia Ahmed
Journal:  Infect Dis (Lond)       Date:  2022-03-29

2.  Can I go back to work? A case of persistent SARS-CoV-2 with advanced untreated HIV infection.

Authors:  Rhys D Wenlock; Colin S Brown; Collins Iwuji; Jaime H Vera
Journal:  Int J STD AIDS       Date:  2021-11-27       Impact factor: 1.359

3.  Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients.

Authors:  M Veronica Dioverti; David C Gaston; C Paul Morris; Carol Ann Huff; Tania Jain; Richard Jones; Viki Anders; Howard Lederman; Jacqueline Saunders; Heba H Mostafa; Robin K Avery
Journal:  Open Forum Infect Dis       Date:  2022-05-26       Impact factor: 4.423

4.  Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4+ T cell count.

Authors:  Wu Menghua; Zheng Xin; Liu Jianwei; Zhang Yu; Yao Qinwei
Journal:  AIDS Res Ther       Date:  2020-07-23       Impact factor: 2.250

5.  SARS-CoV-2 evolution during treatment of chronic infection.

Authors:  Steven A Kemp; Dami A Collier; Rawlings P Datir; Isabella A T M Ferreira; Salma Gayed; Aminu Jahun; Myra Hosmillo; Chloe Rees-Spear; Petra Mlcochova; Ines Ushiro Lumb; David J Roberts; Anita Chandra; Nigel Temperton; Katherine Sharrocks; Elizabeth Blane; Yorgo Modis; Kendra E Leigh; John A G Briggs; Marit J van Gils; Kenneth G C Smith; John R Bradley; Chris Smith; Rainer Doffinger; Lourdes Ceron-Gutierrez; Gabriela Barcenas-Morales; David D Pollock; Richard A Goldstein; Anna Smielewska; Jordan P Skittrall; Theodore Gouliouris; Ian G Goodfellow; Effrossyni Gkrania-Klotsas; Christopher J R Illingworth; Laura E McCoy; Ravindra K Gupta
Journal:  Nature       Date:  2021-02-05       Impact factor: 69.504

6.  COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies.

Authors:  Muhammad Yousaf; Mansoor Hameed; Hussam Alsoub; Mohamad Khatib; Wasim Jamal; Mushtaq Ahmad
Journal:  Clin Case Rep       Date:  2021-01-13

7.  Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.

Authors:  Michael I Barton; Stuart A MacGowan; Mikhail A Kutuzov; Omer Dushek; Geoffrey John Barton; P Anton van der Merwe
Journal:  Elife       Date:  2021-08-26       Impact factor: 8.140

8.  Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.

Authors:  Bina Choi; Manish C Choudhary; James Regan; Jeffrey A Sparks; Robert F Padera; Xueting Qiu; Isaac H Solomon; Hsiao-Hsuan Kuo; Julie Boucau; Kathryn Bowman; U Das Adhikari; Marisa L Winkler; Alisa A Mueller; Tiffany Y-T Hsu; Michaël Desjardins; Lindsey R Baden; Brian T Chan; Bruce D Walker; Mathias Lichterfeld; Manfred Brigl; Douglas S Kwon; Sanjat Kanjilal; Eugene T Richardson; A Helena Jonsson; Galit Alter; Amy K Barczak; William P Hanage; Xu G Yu; Gaurav D Gaiha; Michael S Seaman; Manuela Cernadas; Jonathan Z Li
Journal:  N Engl J Med       Date:  2020-11-11       Impact factor: 91.245

9.  Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

Authors:  John Frater; Katie J Ewer; Ane Ogbe; Mathew Pace; Sandra Adele; Emily Adland; Jasmini Alagaratnam; Parvinder K Aley; Mohammad Ali; M Azim Ansari; Anna Bara; Mustapha Bittaye; Samantha Broadhead; Anthony Brown; Helen Brown; Federica Cappuccini; Enya Cooney; Wanwisa Dejnirattisai; Christina Dold; Cassandra Fairhead; Henry Fok; Pedro M Folegatti; Jamie Fowler; Charlotte Gibbs; Anna L Goodman; Daniel Jenkin; Mathew Jones; Rebecca Makinson; Natalie G Marchevsky; Yama F Mujadidi; Hanna Nguyen; Lucia Parolini; Claire Petersen; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Hannah Robinson; Nicola Robinson; Patpong Rongkard; Fiona Ryan; Sonia Serrano; Timothy Tipoe; Merryn Voysey; Anele Waters; Panagiota Zacharopoulou; Eleanor Barnes; Susanna Dunachie; Philip Goulder; Paul Klenerman; Gavin R Screaton; Alan Winston; Adrian V S Hill; Sarah C Gilbert; Andrew J Pollard; Sarah Fidler; Julie Fox; Teresa Lambe
Journal:  Lancet HIV       Date:  2021-06-18       Impact factor: 12.767
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.